Groundbreaking Study Shows Weight-Loss Drugs Offer Surprising Health Benefits – But Come with Risks
A new study has uncovered both promising and concerning findings about blockbuster weight-loss drugs such as Wegovy, Ozempic, and Zepbound, revealing that they do more than help with weight loss. These medications, which belong to the GLP-1 receptor agonist class, have been linked to a reduced risk of conditions like addiction, schizophrenia, and Alzheimer’s disease, […]
Continue Reading